LIFD

LFTD PARTNERS INC.
2 filings tracked
consumer discretionarywellness productsMICRO (<$300M)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

LFTD Partners is executing a strategic "clean the slate" restructuring designed to insulate the company from looming regulatory headwinds.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

The latest filing reveals a company in a state of operational and regulatory collapse rather than a strategic pivot. A massive $5.06 million inventory reserve serves as a tacit admission that a significant portion of the company's product line is now unsellable.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every LIFD filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The 10-Q presents a stark dichotomy between a managed balance sheet reset and a fundamental business failure. On one hand, LFTD has successfully reduced its debt and is attempting to monetize real estate to fund a transition away from hemp. On the other, the magnitude of the impairments—including a total write-off of $22.3 million in goodwill—suggests that the previous valuation of the business was based on assumptions that are no longer tenable. Ultimately, the company's survival hinges on its ability to accelerate the shift to non-hemp products before the November 2026 federal ban takes effect. While the positive operating cash flow is a glimmer of hope, the negative gross margins and material weaknesses in internal controls create a high-risk environment. Investors are left to decide if this is a disciplined de-risking event or the final stages of a regulatory implosion.

Selected Quarter

Core Takeaway

The company is aggressively writing off assets to prepare for a federal hemp ban, but core operations are currently losing money on a unit basis.

Investor Lens

The trade-off is between believing in management's ability to pivot to a new product mix versus the reality of a shrinking market and failing internal controls.

Watch Next

The sale of the Kenosha manufacturing facility and the actual impact of the November 2026 federal ban on revenue.

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)-0.51Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bearishMay 15

Reported a net loss of $4.16 million for the quarter.

earnings miss
90%
bearishMay 15

Gross profit turned negative due to massive inventory reserves and rising COGS.

margin compression
80%
bullishMay 15

Paid off $1.41 million working capital loan and secured covenant waivers.

debt restructure
60%
bearishMay 15

Facing a potential national ban on intoxicating hemp products by November 2026.

regulatory action
95%
bearishMay 15

Reported a net loss of $4.16 million for the quarter.

earnings miss
90%
bearishMay 15

Gross profit turned negative due to massive inventory reserves and rising COGS.

margin compression
80%
bullishMay 15

Paid off $1.41 million working capital loan and secured covenant waivers.

debt restructure
60%
bearishMay 15

Facing a potential national ban on intoxicating hemp products by November 2026.

regulatory action
95%

Filing History

10-QMay 15, 2026
Expand Sequence

The 10-Q presents a stark dichotomy between a managed balance sheet reset and a fundamental business failure. On one hand, LFTD has successfully reduced its debt and is attempting to monetize real estate to fund a transition away from hemp. On the other, the magnitude of the impairments—including a total write-off of $22.3 million in goodwill—suggests that the previous valuation of the business was based on assumptions that are no longer tenable. Ultimately, the company's survival hinges on its ability to accelerate the shift to non-hemp products before the November 2026 federal ban takes effect. While the positive operating cash flow is a glimmer of hope, the negative gross margins and material weaknesses in internal controls create a high-risk environment. Investors are left to decide if this is a disciplined de-risking event or the final stages of a regulatory implosion.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.